Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Should PTSC inform shareholders of new Licencing Fee strategy?

One would think that PTSC could, would and should announce that licensing fees are being collected as one time fees or in payments over time. Shareholders have been led to believe that license fees are one time payments. We should know if this has changed and I dont see how it would effect the NDA by diclosing this information. This alone would launch our SP pretty good one would think.

All the best,

Steve

2
Apr 22, 2008 10:33AM
Share
New Message
Please login to post a reply